Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not ... for one two-week sensor and £300 for four. There are more than 25 million type ...

A sensor-augmented pump (SAP) combines the technology of an insulin pump with a continuous ... South Dartmouth (MA): MDText.com, Inc. Dexcom.com. The Dexcom CGM difference. U.S. Food and Drug ...

We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...

A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern ...

For thousands of people across the country, access to the Dexcom G7 sensor is strained because of ... to do because we see that if they have that CGM on, it’s more reliable,” said Dr.

In this Healio Video Exclusive, Caroline T. Nguyen, MD, speaks with Sarit Polsky, MD, MPH, about the use of continuous glucose monitoring for pregnant women with gestational diabetes and type 1 ...

Stelo CGM Launch: In August 2024, DexCom announced the commercial launch of Stelo CGM, the first over-the-counter glucose sensor in the U.S. for non-insulin using Type 2 diabetes and prediabetes ...

Rival Abbott launched its own OTC CGM, Lingo, weeks after Dexcom's Stelo debut. The company is counting on further international expansion to drive growth after it said it had improved access to ...

The FDA cited issues with DexCom’s response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...